Clinical Trial

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

Name: A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata — clinical trial record (NCT07762443)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a multicenter, open-label, non-randomized, dose-finding Phase I study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with severe alopecia areata (AA).

Trial Details

NCT Number	NCT07762443
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Alopecia Areata
Enrollment	24 participants
Start Date	2026-09-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-13